| Serial Number | 99036193 |
| Word Mark | MEDERA |
| Filing Date | Tuesday, February 11, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, January 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Blood bank services; Human tissue bank services; Organ and tissue bank services; Stem cell therapy services; Medical services; Consultancy in the field of the medical treatment and diagnosis of cardiovascular diseases |
| Goods and Services | Bacteriological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biomedical research services for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Chemical research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research in the nature of conducting clinical trials for others; Conducting early evaluations for others in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Development of biopharmaceutical preparations and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Drug discovery services for others; Engineering services for others, particularly technical project planning and design engineering of lines for the processing of web products; Industrial research for others in the field of regenerative and reparative gene and cell therapies; Medical research laboratory services for others; Pharmaceutical research services for others; Pharmaceutical drug development services for others for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Pharmaceutical product evaluation for others; Providing medical and scientific research information for others in the field of pharmaceuticals and clinical trials; Research and development of new products for others; Research and development of vaccines and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research for others in the field of gene therapy; Stem cell research services for others; Technical research for others in the field of pharmaceutical studies; Technology research for others in the field of regenerative gene and cell therapies |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, October 27, 2022 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 11, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, April 1, 2021 |
| First Use In Commerce Date | Thursday, October 27, 2022 |
| Party Name | Medera Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Boston, MA 02210 |
| Event Date | Event Description |
| Tuesday, February 11, 2025 | NEW APPLICATION ENTERED |
| Tuesday, February 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 18, 2025 | ASSIGNED TO EXAMINER |
| Friday, July 18, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, July 18, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, July 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 13, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, October 13, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, January 16, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 16, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 16, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 21, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 21, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 21, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |